<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01654627</url>
  </required_header>
  <id_info>
    <org_study_id>RGD001</org_study_id>
    <nct_id>NCT01654627</nct_id>
  </id_info>
  <brief_title>Guided Bone Regeneration Using Synthetic Membrane</brief_title>
  <official_title>Horizontal Guided Bone Regeneration for Dental Implants Using Synthetic Membrane (Regenecures' AMCA GBR Dental Membrane) a Prospective, Randomized,Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RegeneCure, Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RegeneCure, Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the safety and usefulness of the Regenecure guided&#xD;
      bone regeneration membrane for stimulating bone growth in patients that don't have enough&#xD;
      bone for dental implant placement. The study will include 16 patients in each group, 20&#xD;
      non-smokers and 12 smokers, a total of 32 patients will participate in the study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone volume</measure>
    <time_frame>Change from Baseline in bone volume at 6 months</time_frame>
    <description>Clinical effect on bone volume measured using CBCT. The volume of the newly formed bone will be evaluated by &quot;subtraction&quot; of the 2 cone beam CTs using digital measurements.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Histomorphometry</measure>
    <time_frame>6 months</time_frame>
    <description>Specimens will be prepared for histological staining (H&amp;E and Masson's trichrome stain). The stained samples will be evaluated for new bone, residual bone graft, marrow spaces and vascularity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety will be demonstrated by using VAS scale for pain measurements and if the PI will consider that any adverse event device related isn't clinically significant</measure>
    <time_frame>six months</time_frame>
    <description>Safety will be demonstrated by using VAS scale for pain measurements and if the PI will consider that any adverse event device related isn't clinically significant</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Jaw, Edentulous</condition>
  <condition>Jaw, Edentulous, Partially</condition>
  <arm_group>
    <arm_group_label>Regenecure AMCA GBR Dental membrane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>16 patients will undergo the guided bone regeneration procedure using the Regenecure AMCA Membrane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Collagen membrane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>16 patients will undergo the guided bone regeneration procedure using a commercially available collagen membrane</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Regenecure AMCA GBR Dental Membrane</intervention_name>
    <description>Patients will undergo Guided Bone Regeneration (GBR) procedure using the Regenecure AMCA GBR Membrane</description>
    <arm_group_label>Regenecure AMCA GBR Dental membrane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Geistlich Bio-Gide® collagen membrane</intervention_name>
    <description>The Geistlich Bio-Gide® collagen membrane, a commercially available product, will be used in 10 patients.</description>
    <arm_group_label>Collagen membrane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject must have voluntarily signed the informed consent form before any study&#xD;
             related action&#xD;
&#xD;
          -  Age: 18 to 65 with missing teeth, seeking for implant therapy.&#xD;
&#xD;
          -  Men/Women&#xD;
&#xD;
          -  In good systemic health&#xD;
&#xD;
          -  Present with no contra indication against oral surgical interventions&#xD;
&#xD;
          -  Single/ multiple tooth gap - have at least one missing tooth in the mandible or&#xD;
             maxilla, requiring one or more dental implants.&#xD;
&#xD;
          -  The tooth at the implant site(s) must have been extracted or lost at least 6 weeks&#xD;
             before the date of implantation.&#xD;
&#xD;
          -  Bone defect(s) must be present with a lateral dimension greater than or equal to 5 mm&#xD;
             or less.&#xD;
&#xD;
          -  Full mouth plaque score (FMPI) lower or equal than 25%&#xD;
&#xD;
          -  Patients must be committed to the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Medical conditions requiring prolonged use of steroids&#xD;
&#xD;
          -  Use of Bisphosphonate intravenously&#xD;
&#xD;
          -  Current pregnancy or breastfeeding women&#xD;
&#xD;
          -  Alcoholism or chronically drug abuse&#xD;
&#xD;
          -  Immunocompromised patients&#xD;
&#xD;
          -  Uncontrolled Diabetes&#xD;
&#xD;
          -  Conditions or circumstances, in the opinion of the investigator, which would prevent&#xD;
             completion of study participation or interfere with analysis of study results, such as&#xD;
             history of non-compliance, or unreliability.&#xD;
&#xD;
          -  Untreated inflammation&#xD;
&#xD;
          -  Mucosal diseases or oral lesions&#xD;
&#xD;
          -  History of local irradiation therapy&#xD;
&#xD;
          -  Persistent intraoral infection&#xD;
&#xD;
          -  Patients with bad oral hygiene or unmotivated for normal home care.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lior Shapira, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Haddasah Medical Center, Jerusalem Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michal Limor, MD</last_name>
    <phone>+ 972-2-5401013</phone>
    <email>michal@regenecure.co.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Periodontology Hadassah and Hebrew University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <study_first_submitted>July 26, 2012</study_first_submitted>
  <study_first_submitted_qc>July 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2012</study_first_posted>
  <last_update_submitted>August 26, 2013</last_update_submitted>
  <last_update_submitted_qc>August 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Guided Tissue Regeneration</keyword>
  <keyword>Dental Implants</keyword>
  <keyword>Membrane, Synthetic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Jaw, Edentulous</mesh_term>
    <mesh_term>Jaw, Edentulous, Partially</mesh_term>
    <mesh_term>Mouth, Edentulous</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

